Inhibrx Biosciences, Inc. · NASDAQ:INBX
BlackRock, Inc.'s stake in Inhibrx Biosciences, Inc. fell to 4.70% (Schedule 13G/A)
Event Sep 30, 2025 · Filed Oct 17, 2025
BlackRock, Inc.'s stake in Inhibrx Biosciences, Inc. fell to 4.70%, 680,368 shares, as a passive investor on Sep 30, 2025. Filed Oct 17, 2025 (Schedule 13G/A).
- Stake
- 4.70%
- Shares
- 680,368
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 4.70% | 680,368 |
Source
Related
- Inhibrx Biosciences, Inc.
- BlackRock, Inc.
- Inhibrx Biosciences, Inc. shareholders
- Schedule 13G · BlackRock, Inc. · Jan 21, 2026
- Schedule 13G · BlackRock, Inc. · Feb 4, 2025
- Form 4 · Lappe Mark · Oct 14, 2026
- Form 4 · Lappe Mark · Sep 28, 2026
- Form 4 · Kayyem Jon Faiz · Sep 23, 2026
- Form 4 · Kayyem Jon Faiz · Sep 17, 2026
- Form 4 · Manhard Kimberly · Sep 15, 2026